Show simple item record

Small cell lung cancer; comparison of 2 realities

Carcinoma brônquico de pequenas células: comparação entro 2 realidades

dc.creatorThomson, Márcia
dc.creatorCascardo, Marcos Augusto Rocha
dc.creatorJoaquim, Daniela Matsunaga
dc.creatorSantos, Sérgio Ricardo Rodrigues de Almeida
dc.creatorSimm, Renata Faria
dc.creatorThomson, João Carlos
dc.date2004-12-15
dc.date.accessioned2022-10-18T19:44:28Z
dc.date.available2022-10-18T19:44:28Z
dc.identifierhttps://ojs.uel.br/revistas/uel/index.php/seminabio/article/view/7067
dc.identifier10.5433/1679-0367.1996v17n2p146
dc.identifier.urihttp://www.labtecgc.udesc.br/tabd1/handle/123456789/900
dc.descriptionThe Small Cell Lung Cancer (SCI C) accounts for 15 a 35% of all bronchial carcinomas. Undertaking a retrospective review we've compared cases of SCLC from the Hospital Universitario Regional do Norte do Parana and Hospital Evangelico de Londrina to cases from the Brompton Hospital of London. During the studied period, 15 patients with SCLC from Londrina were compared to 37 patients from London. We've found only 2 (13,3%) patients at stages I, II. llIa (with no lymphnode involvement), and 13 (86,7%) at lllb and IV in Londrina, compared to 30 (34.5%) and 57(65,5%), respectively, at the Brompton Hospital. Two cases (13,3%) were considered operable in Londrina (only 1 ressection) and 30 (34,5%) in London (93,3'% resectable). The treatment in Londrina was basically non-surgical (86,7%), the survival rate observed was less than 3 months in 3 (53,8%) patients, we've lost the follow up of 4 (26,7%) and 3 (19,5%) are still in observation; in London, with exclusive surgical treatment 38 patients (43,3%) presented overall 5-year survival rate. The surgical treatment of SCLC depends basically on staging. The indication of surgery in the 15 patient group was limited by the advanced stage of the disease at diagnose, differently from London. These findings show the importance of early diagnoses, as seen at the Brompton Hospital, offering the possibility of cure, a reality different from the observed in Londrina.en-US
dc.descriptionO câncer de pequenas células (SCLC) representa 15 a 35% dos carcinoma brônquicos. Através de estudo retrospectivo comparou-se pacientes atendidos no HURNPr/UEL (Londrina) e no Brompton Hospital (Londres). Foram estudados 15 pacientes com diagnostico de SCLC e comparados aos 87 pacientes anlisados no Brompton Hospital. Estadios I, II e IIIa ( sem comprometimento do linfonodos) foram encontrados em 2 pacientes (13,3%) c estadios Illa (comprometendo linfonodos), IIIb e IV em 13 (86,7%) dos pacientes no estudo de Londrina, comparados a 30 (34,5%) e 57 (65,5%), respectivamente no Brompton Hospital. Foram considerados operáveis apenas 2 (13,3%) casos em Londrina (apenas 1 ressecável) contra 30 (34,5%) em Londres (93,3% ressecáveis). O tratamento no grupo de Londrina foi baspt-BR
dc.formatapplication/pdf
dc.languagepor
dc.publisherUniversidade Estadual de Londrinapt-BR
dc.relationhttps://ojs.uel.br/revistas/uel/index.php/seminabio/article/view/7067/6287
dc.rightsCopyright (c) 2016 Semina: Ciências Biológicas e da Saúdept-BR
dc.sourceSemina: Ciências Biológicas e da Saúde; Vol. 17 No. 2 (1996); 146-148en-US
dc.sourceSemina: Ciências Biológicas e da Saúde; v. 17 n. 2 (1996); 146-148pt-BR
dc.source1679-0367
dc.source1676-5435
dc.subjectSCLCen-US
dc.subjectLung Canceren-US
dc.subjectOat cell.en-US
dc.subjectSCLCpt-BR
dc.subjectLung Cancerpt-BR
dc.subjectOat cell.pt-BR
dc.titleSmall cell lung cancer; comparison of 2 realitiesen-US
dc.titleCarcinoma brônquico de pequenas células: comparação entro 2 realidadespt-BR
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeArtigo avaliado pelos Parespt-BR


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record